The Prognostic Roles of Systemic Inflammatory Markers Before Abiraterone or Enzalutamide Therapy in Metastatic Castration-Resistant Prostate Cancer.

J Clin Med · 2025 · PMC12470515 · PMID 41010740

Europe PMC DOI

hedged sentence

0.0650

closest p · 1.3× alpha

0.0650

boldest claim

The sentences

did not reach statistical significancep = 0.065so close (0.05 < p ≤ 0.1)

showed a trendp = 0.065so close (0.05 < p ≤ 0.1)

Although elevated PLR showed a trend toward increased risk of progression, it did not reach statistical significance (HR: 1.720, 95% CI: 0.967–3.061; p = 0.065).

also in 35,913 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.